366
Participants
Start Date
September 30, 2014
Primary Completion Date
May 31, 2017
Study Completion Date
August 31, 2017
EV71 with adjuvant aluminium phosphate
Two arms, EV71 with aluminium phosphate
Placebo
Phosphate Buffer Saline with adjuvant aluminium phosphate
Chang-Guang Memorial Hospital Lin-Kou, Taipei
Far Eastern Memorial Hospital, Taipei
MacKay Memorial Hospital, Taipei
National Taiwan University Hosptial, Taipei
Lead Sponsor
Medigen Vaccine Biologics Corp.
INDUSTRY